Change - Announcement of Cessation::Cessation of Executive Director

Issuer & Securities

Issuer/ Manager
TALKMED GROUP LIMITED
Securities
TALKMED GROUP LIMITED - SG2G61000003 - 5G3
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
10-Nov-2023 17:50:57
Status
New
Announcement Sub Title
Cessation of Executive Director
Announcement Reference
SG231110OTHRL7UI
Submitted By (Co./ Ind. Name)
Lee Boon Yong
Designation
Chief Financial Officer
Description (Please provide a detailed description of the event in the box below)
Cessation of Dr Khoo Kei Siong as Executive Director.

Additional Details

Name Of Person
Khoo Kei Siong
Age
61
Is effective date of cessation known?
Yes
If yes, please provide the date
31/12/2023
Detailed Reason (s) for cessation
Dr Khoo Kei Siong will step down as Executive Director to facilitate the Board renewal process.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
10/09/2013
Does the AC have a minimum of 3 members (taking into account this cessation)?
No
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
0
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director and Chief Operating Officer
Role and responsibilities
Dr Khoo oversees the daily administrative and operational functions of our Group.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Nil
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Dr Khoo has a deemed interest of 99,360,000 ordinary shares in the Company.
Past (for the last 5 years)
Academy of Medicine Singapore
CellVec Pte. Ltd.
Stem Med Pte. Ltd.
Present
Singapore Cancer Centre Pte. Ltd.
AYSUS Pte. Ltd.
TalkMed Vietnam Pte. Ltd.
Hong Kong Integrated Oncology Centre Holdings Limited
Hong Kong Integrated Oncology Centre Limited
TalkMed China Pte. Ltd.
TalkMed Chongqing Pte. Ltd.
TalkMed Greater China Pte. Ltd.
TalkMed Hospital Management (Beijing) Co., Ltd.
Beijing Yachuang Siwei Investment Management Co., Ltd.
Stem Med Indonesia Pte. Ltd.
BioCell Innovations Pte. Ltd.